US Patent Issued to Cambridge Cognition on April 7 for "Schizophrenic disorder treatment using combination therapy" (British Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,270, issued on April 7, was assigned to Cambridge Cognition Ltd. (Cambridge, Great Britain).

"Schizophrenic disorder treatment using combination therapy" was invented by Kiri Granger (Kilby, Great Britain) and Jennifer Barnett (Burwell, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification disclose a combined therapy comprising one or more activators of an alpha-7 nicotinic acetylcholine receptor activity having 5-HT3 receptor inhibitory activity and one or more activators of 5-HT3 receptor activity for use in treating a schizophrenic disorder as well as methods of treating a schizophrenic disorder by administering a...